当前位置： SCI文献检索 > ONCOGENE期刊下所有文献 > Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

Abstract：

:In lung cancer, frequent loss of one allele of chromosome 3p is seen in both small cell lung cancer and non-small cell lung cancer (NSCLC), providing evidence of tumor suppressor genes (TSGs) in this chromosomal region. The mechanism of Fus1 tumor suppressor activity is unknown. We have found that a Fus1 peptide inhibits the Abl tyrosine kinase in vitro (IC(50) 35 microM). The inhibitory Fus1 sequence was derived from a region that was deleted in a mutant FUS1 gene (FUS1 (1-80)) detected in some lung cancer cell lines. Importantly, a stearic acid-modified form of this peptide was required for the inhibition, but stearic acid alone was not inhibitory. Two NSCLC cell lines, which lack expression of wild-type Fus1, contain activated c-Abl. Forced expression of an inducible FUS1 cDNA in H1299 NSCLC cells decreased levels of activated c-Abl and inhibited its tyrosine kinase activity. Similarly, treatment of c-Abl immune complexes with the inhibitory Fus1 peptide also reduced the level of c-Abl in these immune complexes. The size and number of colonies of the NSCLC cell line, H1,299, in soft agar was strongly inhibited by the Abl kinase inhibitor imatinib mesylate. Co-expression of FUS1 and c-ABL in COS1 cells blocked activation of c-Abl tyrosine kinase. In contrast, co-expression of mutant FUS1 (1-80) with c-ABL had little inhibitory activity against c-Abl. These findings provide strong evidence that c-Abl is a possible target in NSCLC patients that have reduced expression of Fus1 in their tumor cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Lin J,Sun T,Ji L,Deng W,Roth J,Minna J,Arlinghaus R

doi

10.1038/sj.onc.1210500

subject

Has Abstract

pub_date

2007-10-25 00:00:00

pages

6989-96

issue

49

eissn

0950-9232

issn

1476-5594

pii

1210500

journal_volume

26

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer.

    abstract：:Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates a variety of cellular functions such as growth, proliferation and autophagy. In a variety of cancer cells, overactivation of mTOR has been reported. In addition, mTOR inhibitors, such as rapamycin and its derivatives, are being evaluated ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2010.28

    authors： Sato T,Nakashima A,Guo L,Coffman K,Tamanoi F

    更新日期：2010-05-06 00:00:00

  • Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.

    abstract：:The transcription factor activator protein-1 (AP-1) has been implicated in a large variety of biological processes including cell differentiation, proliferation, apoptosis and oncogenic transformation. It is thought that the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced AP-1 activity is because of the activation ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206102

    authors： Li J,Ma C,Huang Y,Luo J,Huang C

    更新日期：2003-01-16 00:00:00

  • Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha.

    abstract：:A previous report demonstrated that AP-2alpha favors the survival of ovarian cancer patients by clinical findings. However, the functional roles of AP-2alpha in human ovarian cancers have not been determined. To clarify the roles, we overexpressed AP-2alpha in SKOV3 human ovarian cancer cells, which originally possess...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1207723

    authors： Sumigama S,Ito T,Kajiyama H,Shibata K,Tamakoshi K,Kikkawa F,Williams T,Tainsky MA,Nomura S,Mizutani S

    更新日期：2004-07-15 00:00:00

  • Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta.

    abstract：:To evaluate the role of the NF-kappaB signaling pathway in oncogenic transformation, we expressed IkappaBbeta, a specific inhibitor of NF-kappaB, in two human lung adenocarcinoma cell lines, A549 and H441. Expression of IkappaBbeta significantly reduced NF-kappaB activation induced by cotransfection with p65/RelA or T...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1204293

    authors： Jiang Y,Cui L,Yie TA,Rom WN,Cheng H,Tchou-Wong KM

    更新日期：2001-04-26 00:00:00

  • Essential roles of Crk and CrkL in fibroblast structure and motility.

    abstract：:Cytosolic proteins containing SH2 and SH3 domains, such as Crk and Crk-like (CrkL), are broadly expressed adapters that interact with a variety of proteins to fulfill key roles in signal transduction pathways triggered by activation of receptor and non-receptor tyrosine kinases. Crk and CrkL are similar to each other ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2013.453

    authors： Park TJ,Curran T

    更新日期：2014-10-23 00:00:00

  • Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA.

    abstract：:Adenoviruses are linear double-stranded DNA viruses that infect human and rodent cell lines, occasionally transform them and cause tumors in animal models. The host cell challenges the virus in multifaceted ways to restrain viral gene expression and DNA replication, and sometimes even eliminates the infected cells by ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.534

    authors： Gupta A,Jha S,Engel DA,Ornelles DA,Dutta A

    更新日期：2013-10-17 00:00:00

  • Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.

    abstract：:Telomerase-negative cancer cells can maintain their telomeres by a recombination-mediated alternative lengthening of telomeres (ALT) process. We reported previously that sequestration of MRE11/RAD50/NBS1 complexes represses ALT-mediated telomere length maintenance, and suppresses formation of ALT-associated promyelocy...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210260

    authors： Jiang WQ,Zhong ZH,Henson JD,Reddel RR

    更新日期：2007-07-12 00:00:00

  • Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium.

    abstract：:We previously described the oral-esophageal tissue-specific expression of cyclin D1 with the Epstein-Barr virus ED-L2 promoter in transgenic mice, and resulting dysplasia. Given the evidence for an interplay between environmental and genetic factors in esophageal squamous carcinogenesis, the aim of this study was to d...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202296

    authors： Jenkins TD,Mueller A,Odze R,Shahsafaei A,Zukerberg LR,Kent R,Stoner GD,Rustgi AK

    更新日期：1999-01-07 00:00:00

  • DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.

    abstract：:Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We p...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2016.399

    authors： Fan H,Cui Z,Zhang H,Mani SK,Diab A,Lefrancois L,Fares N,Merle P,Andrisani O

    更新日期：2017-04-27 00:00:00

  • TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.

    abstract：:Epidermal growth factor receptor (EGFR) family members play pivotal roles in cell proliferation, differentiation and survival. Overexpression and mutations of EGFRs, or aberrant EGFR signaling are commonly associated with the development of various cancers, where constitutive NF-κB activation is often found to promote...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2016.430

    authors： Jiang C,Zhu Y,Zhou Z,Gumin J,Bengtsson L,Wu W,Songyang Z,Lang FF,Lin X

    更新日期：2017-05-18 00:00:00

  • Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.

    abstract：:The hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumour adaptation to microenvironmental hypoxia, and represents an appealing chemotherapeutic target. Silibinin is a nontoxic flavonoid reported to exhibit anticancer properties. However, the mechanisms by which silibinin inhibits tumour growth are not f...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2008.398

    authors： García-Maceira P,Mateo J

    更新日期：2009-01-22 00:00:00

  • Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis.

    abstract：:We have previously shown that tumor necrosis factor (TNF)α produced from primary tumor-induced expression of two endogenous Toll-like receptor 4 (TLR4) ligands, S100A8 and serum amyloid A3 (SAA3), in pre-metastatic lungs. However, mechanistic details of the signaling network and relevance to pulmonary physiology are p...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2011.53

    authors： Tomita T,Sakurai Y,Ishibashi S,Maru Y

    更新日期：2011-08-04 00:00:00

  • The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene.

    abstract：:Keratinocyte growth factor is a potent and specific mitogen for different types of epithelial cells, including keratinocytes of the skin. Furthermore, it has been implicated in morphogenetic processes of several organs. To further define the mechanisms of KGF action in the skin, we attempted to identify genes which ar...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1200905

    authors： Frank S,Munz B,Werner S

    更新日期：1997-02-27 00:00:00

  • Molecular interdiction of Src-family kinase signaling in hematopoietic cells.

    abstract：:The ability of Src-family kinases (SFKs) to mediate signaling from cell surface receptors in hematopoietic cells is a function of their catalytic activity, location and binding partners. Kinase activity is regulated in the cell by kinases and phosphatases that alter the state of phosphorylation of key tyrosine residue...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1208078

    authors： Geahlen RL,Handley MD,Harrison ML

    更新日期：2004-10-18 00:00:00

  • Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity.

    abstract：:The FOXO family of Forkhead transcription factors, regulated by the phosphoinositide-3-kinase-Akt pathway, is involved in cell cycle regulation and apoptosis. Strong expression of HER2, a receptor tyrosine kinase oncogene, in cancers has been associated with a poor prognosis. Recently, FOXO4 was shown to regulate the ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208352

    authors： Yang H,Zhao R,Yang HY,Lee MH

    更新日期：2005-03-10 00:00:00

  • Mutations that abolish the ability of Ha-Ras to associate with Raf-1.

    abstract：:Recent studies have revealed that Ras can associate physically with Raf. In the present study, we tested 34 mutants of Ha-Ras carrying substitution(s) in the region of residues 23-71 for their ability to associate with Raf-1. Mouse Ba/F3 cell lysates were incubated with each mutant Ras protein, in either the guanosine...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Shirouzu M,Koide H,Fujita-Yoshigaki J,Oshio H,Toyama Y,Yamasaki K,Fuhrman SA,Villafranca E,Kaziro Y,Yokoyama S

    更新日期：1994-08-01 00:00:00

  • Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A.

    abstract：:Trichostatin A (TSA), a histone deacetylase inhibitor, strongly increases acetylation of the N-terminal tails of histone H3. Many studies have correlated the function of TSA with the hyperacetylation of histone. Although histone H3 is known to be phosphorylated, the effect of acetylation on phosphorylation is not know...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206507

    authors： Zhong S,Goto H,Inagaki M,Dong Z

    更新日期：2003-08-14 00:00:00

  • Rho GTPases: Anti- or pro-neoplastic targets?

    abstract：:Rho GTPases are critical signal transducers of multiple pathways. They have been proposed to be useful anti-neoplastic targets for over two decades, especially in Ras-driven cancers. Until recently, however, few in vivo studies had been carried out to test this premise. Several recent mouse model studies have verified...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/onc.2016.473

    authors： Zandvakili I,Lin Y,Morris JC,Zheng Y

    更新日期：2017-06-08 00:00:00

  • Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.

    abstract：:Lysyl oxidase (LOX) is a multifunctional protein required for normal collagen and elastin biosynthesis and maturation. In addition, LOX has complex roles in cancer in which the lysyl oxidase propeptide (LOX-PP) domain of secreted pro-LOX has tumor-suppressor activity, while the active enzyme promotes metastasis. In pr...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2014.147

    authors： Bais MV,Ozdener GB,Sonenshein GE,Trackman PC

    更新日期：2015-04-09 00:00:00

  • The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

    abstract：:Small cell lung cancer (SCLC) is a disease characterized by aggressive clinical behavior and lack of effective therapy. Owing to its tendency for early dissemination, only a third of patients have limited-stage disease at the time of diagnosis. SCLC is thought to derive from pulmonary neuroendocrine cells. Although se...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.362

    authors： Kalari S,Jung M,Kernstine KH,Takahashi T,Pfeifer GP

    更新日期：2013-07-25 00:00:00

  • DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.

    abstract：:DAL-1 (differentially expressed in adenocarcinoma of the lung)/4.1B is a tumor suppressor gene on human chromosome 18p11.3 whose expression is lost in >50% of primary non-small-cell lung carcinomas. Based on sequence similarity, DAL-1/4.1B has been assigned to the Protein 4.1 superfamily whose members interact with pl...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208057

    authors： Singh V,Miranda TB,Jiang W,Frankel A,Roemer ME,Robb VA,Gutmann DH,Herschman HR,Clarke S,Newsham IF

    更新日期：2004-10-14 00:00:00

  • Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis).

    abstract：:We have determined the genomic structure of the mouse fra-1 gene, which consists of four exons and three introns at positions also found in the other members of the fos gene family. Fra-1 is expressed rather highly in the brain and testes of adult mice, and at low levels in most other tissues. Absence of c-Fos leads t...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201460

    authors： Schreiber M,Poirier C,Franchi A,Kurzbauer R,Guenet JL,Carle GF,Wagner EF

    更新日期：1997-09-04 00:00:00

  • Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists.

    abstract：:Detachment of non-malignant epithelial cells from the extracellular matrix causes their apoptosis, a phenomenon called anoikis. By contrast, carcinoma cells are anoikis-resistant, and this resistance is thought to be critical for tumor progression. Many oncogenes trigger not only anti- but also pr-apoptotic signals. T...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2014.415

    authors： Yoo BH,Masson O,Li Y,Khan IA,Gowda PS,Rosen KV

    更新日期：2015-09-17 00:00:00

  • Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.

    abstract：:The human ret proto-oncogene (proto-ret), encoding a receptor tyrosine kinase, is highly expressed in neuroblastomas, medullary thyroid carcinomas (MTCs) and pheochromocytomas, which are all tumors of cells originating from the neural crest. In studies on the transcription mechanism of proto-ret, we identified the tra...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Itoh F,Ishizaka Y,Tahira T,Yamamoto M,Miya A,Imai K,Yachi A,Takai S,Sugimura T,Nagao M

    更新日期：1992-06-01 00:00:00

  • MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.

    abstract：:MicroRNAs (miRNAs) make up a novel class of gene regulators; they function as oncogenes or tumor suppressors by targeting tumor-suppressor genes or oncogenes. A recent study that analysed a large number of human cancer cell lines showed that miR-330 is a potential tumor-suppressor gene. However, the function and molec...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2009.192

    authors： Lee KH,Chen YL,Yeh SD,Hsiao M,Lin JT,Goan YG,Lu PJ

    更新日期：2009-09-24 00:00:00

  • MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.

    abstract：:Esophageal cancer is one of the most lethal cancers worldwide with poor survival and limited therapeutic options. The discovery of microRNAs created a new milestone in cancer research. miR-377 is located in chromosome region 14q32, which is frequently deleted in esophageal squamous cell carcinoma (ESCC), but the biolo...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2017.29

    authors： Li B,Xu WW,Han L,Chan KT,Tsao SW,Lee NPY,Law S,Xu LY,Li EM,Chan KW,Qin YR,Guan XY,He QY,Cheung ALM

    更新日期：2017-07-13 00:00:00

  • Functional interaction between the small GTP-binding protein Rin and the N-terminal of Brn-3a transcription factor.

    abstract：:Brn-3a is a transcription factor belonging to the class IV of POU domain transcription factors. It is expressed throughout the peripheral nervous system but especially in postmitotic sensory neurons of dorsal root ganglia. Brn-3a is known to regulate different genes involved in neuronal differentiation and survival. I...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206635

    authors： Calissano M,Latchman DS

    更新日期：2003-08-21 00:00:00

  • Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.

    abstract：:Abundant levels of the hyperactive low molecular weight (LMW) forms of cyclin E contribute to deregulation of Cdk2 in breast tumors, but the mechanism through which they arise is not fully understood. Here, we explored the hypothesis that post-translational processing by a protease generates the LMW forms of cyclin E ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206166

    authors： Wang XD,Rosales JL,Magliocco A,Gnanakumar R,Lee KY

    更新日期：2003-02-06 00:00:00

  • Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

    abstract：:RAS is a small GTP binding protein mutated in approximately 30% human cancer. Despite its important role in the initiation and progression of human cancer, the underlying mechanism of RAS-induced human epithelial transformation remains elusive. In this study, we probe the cellular and molecular mechanisms of RAS-media...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208753

    authors： Young T,Mei F,Liu J,Bast RC Jr,Kurosky A,Cheng X

    更新日期：2005-09-08 00:00:00

  • Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

    abstract：:Resistance to TGF-beta1 occurred in pancreatic cancer cells suggesting that inactivation of TGF-beta inhibitory signaling pathways may play an important role in human pancreatic cancer. The aim of our study was to determine the presence of alterations in the main putative components of the TGF-beta inhibitory signalin...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202118

    authors： Villanueva A,García C,Paules AB,Vicente M,Megías M,Reyes G,de Villalonga P,Agell N,Lluís F,Bachs O,Capellá G

    更新日期：1998-10-15 00:00:00